in the Endothelium for Cancer Therapy. Trends in Molecular Medicine. 2017; 23(3):197-200. (IF: 11.021)

　　5、Hou P, Liu D, Shan Y, Hu S, et al. Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res. 2007; 13(4):1161-70. (IF: 10.2)

　　6、Hou P, Liu D, Xing M*. The T1790A BRAF mutation (L597Q) in childhood acute lymphoblastic leukemia is a functional oncogene. Leukemia. 2007; 21(10):2216-8. (IF: 10.023)

　　7、Hou P, Ji M, Ge C, Shen J, Li S, He N, Lu Z*. Detection of methylation of human p16(Ink4a) gene 5'-CpG islands by electrochemical method coupled with linker-PCR. Nucleic Acids Res. 2003; 31(16):e92. (IF: 11.561)

　　8、He W, Yan J, Jiang W, li S, Qu Y, Niu F, Yan Y, Sui F, Wang S, Zhou Y, Jin L, Ji M, Ma PX, Liu M, lu W, Hou P*. Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch. Chem. Mater. 2018; 30:7034-7046. (IF: 9.89)

　　9、Li H, Tian Z, Qu Y, Yang Q, Guan H, Shi B, Ji M, Hou P*. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis. Oncogene. 2018 Aug 9. (IF: 6.854)

　　10、Qu Y, Yang Q, Liu J, Shi B, Ji M, Li G, Hou P*. c-Myc is required for BRAFV600E-induced epigenetic silencing by H3K27me3 in tumorigenesis. Theranostics. 2017; 7(8):2092-2107. (IF: 8.537)

　　11、Hou P*, Chen Z, Ji M, He N, Lu Z*. Real-time PCR assay for ultrasensitive quantification of DNA-binding proteins. Clin Chem. 2007; 53(4):581-6. (IF: 8.636)

　　12、Bian Z, Yan J, Wang S, Li Y, Guo Y, Ma B, Guo H, Lei Z, Yin C, Zhou Y, Liu M, Tao K, Hou P*, He W*. Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery. Theranostics. 2018; 8(19):5320-5335. (IF: 8.537)

　　13、Li Y, Li X, Pu J, Yang Q, Guan H, Ji M, Shi B, Chen M, Hou P*. c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer. Thyroid. 2018 Oct 16. (IF: 7.557)

　　14、Qu Y, Dang S, Wu K, Shao Y, Yang Q, Ji M, Shi B, Hou P*. TERT promoter mutations predict worse survival in laryngeal cancer patients. Int J Cancer. 2014;135(4):1008-1010. (IF: 7.36)

　　15、Qu Y, Shi L, Wang D, Zhang B, Yang Q, Ji M, Shi B, Hou P*. Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers. Int J Cancer. 2014;134(12):2993-2994. (IF: 7.36)

　　其它SCI论文请链接 http://www.ncbi.nlm.nih.gov/pubmed/?term=peng+hou

　　七、联系方式

　　侯鹏：E-mail: phou@xjtu.edu.cn 或 penghou@126.com （邮件标题注明：应聘岗位+毕业院校+本人姓名+高校师资网）

　　　　　Tel: 029-85324749

　　有意者请将简历发至上面的邮箱，欢迎加入！

更多最新博士后招收资讯请关注高才博士后微信公众号（微信号：bshjob）

来源：

http://www.med.xjtu.edu.cn/info/1016/9754.htm

投递招聘简历时请注明来源于：高校师资网 https://www.gxszw.com/,提供博士人才招聘信息、研究生人才招聘信息。为高校、科研机构、事业单位提供各岗位的高层次人才！

更多招聘信息！欢迎扫描下方二维码关注高校师资网官方微信。